Park Ha Biological Technology Co Ltd

Park Ha Biological Technology Co Ltd(BYAH)股票分析

$2.750

-0.059 (-2.14%)收盤時

Loading chart…
High
2.838
Open
2.770
VWAP
2.77
Vol
20.25K
Mkt Cap
Low
2.731
Amount
56.16K
EV/EBITDA, TTM
0.00

Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market.

ir.parkha.cn

AI analysis of Park Ha Biological Technology Co Ltd (BYAH)

sell

Given the current price of $2.75 and a staggering year-to-date change of -95.96%, this asset is not a good buy right now. The RSI is at 38.648, indicating it is nearing oversold territory, but the ongoing class action lawsuit poses a significant risk. The forward P/E ratio is at 0, suggesting uncertainty about future earnings, which further complicates the investment case.

估值指標

The current forward P/E ratio for Park Ha Biological Technology Co Ltd (BYAH) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
高估
0.00
低估
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
高估
0.00
低估
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
高估
0.00
低估
0.00

事件時間軸

2026-08-05 (ET)

20:00:00

Park Ha Biological Technology Co Ltd Trading Halted, News Pending

2026-06-29 (ET)

10:30:00

Park Ha Biological Partners with Amazon for North American Market Entry

2026-06-23 (ET)

09:30:00

Park Ha Biological Establishes Strategic Partnership with Cloud Factory Technology

2026-06-12 (ET)

15:00:00

Park Ha Biological Technology Raises $2M in Direct Offering

09:00:00

Park Ha Biological Partners with Star Plus Action

資訊

BYAH FAQ — answered by Alphio AI

Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market. It operates in the Consumer Non-Cyclicals sector.

Given the current price of $2.75 and a staggering year-to-date change of -95.96%, this asset is not a good buy right now. The RSI is at 38.648, indicating it is nearing oversold territory, but the ongoing class action lawsuit poses a significant risk. The forward P/E ratio is at 0, suggesting uncertainty about future earnings, which further complicates the investment case.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始